Impact of Pulse Steroid on the Level of IL-17 in Active Lupus Nephritis | ||
| Al-Azhar International Medical Journal | ||
| Volume 2024, Issue 7, July 2024 | ||
| DOI: 10.58675/2682-339X.2539 | ||
| Authors | ||
| Eslam Eid1; Farag Farag1; Hassan Gaber2; Mohamed Rafat1 | ||
| 1Internal Medicine, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||
| 2Clinical Pathology, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||
| Abstract | ||
| Background: Lupus nephritis (LN) is one of the most severe conditions associated with systemic lupus erythematosus (SLE). Interleukin-17 is one of the main inflammatory cytokines linked to LN, but the relationship is unclear. Aim of the work: Examine the correlation between the histopathological findings, therapy response, and IL-17 serum level in cases with active LN and following pulse therapy. Patients and methods: The current research divided 60 subjects into active LN, inactive LN, and control groups. Every individual underwent comprehensive history taking, a comprehensive physical examination, an evaluation of disease activity using the SLE disease activity index (SLEDAI), and clinical tests (including serum IL-17 levels). After the induction therapy, cases with active LN were followed up to determine the fate after treatment and to determine changes in the laboratory and urinary tested parameters. Results: Compared to the inactive LN and control groups, the active LN group had statistically significantly higher IL-17 levels. The IL-17 level in the active LN showed a statistically significant decrease after treatment compared to before treatment. Conclusion: In cases of SLE, a higher serum IL-17 level may help predict the level of LN activity. Active LN patients' serum IL-17 levels are predictive of treatment efficacy. | ||
| Keywords | ||
| SLE; LN; IL-17; Remission; steroids | ||
|
Statistics Article View: 26 |
||
